S 
10.50
0.00%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.56bn
FY2016FY2025
Net income
CN¥89.2m
FY2016FY2025
Free cash flow
CN¥23.1m
FY2016FY2025
Shareholders' equity
CN¥1.27bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.56bn | CN¥1.42bn | CN¥1.42bn | CN¥1.35bn | CN¥1.56bn | CN¥1.48bn | CN¥1.33bn | CN¥1.18bn | CN¥1.13bn | CN¥1.06bn |
| Research and development | CN¥51.9m | CN¥43.7m | CN¥27.9m | CN¥30.9m | CN¥34.6m | CN¥32.9m | CN¥28.7m | CN¥21.1m | CN¥14.4m | CN¥7.2m |
| Operating income | CN¥104.7m | CN¥115.1m | CN¥168.9m | CN¥136.8m | CN¥151.2m | CN¥204.9m | CN¥197.9m | CN¥158.9m | CN¥172.7m | CN¥169.0m |
| Net income | CN¥89.2m | CN¥90.3m | CN¥129.0m | CN¥109.6m | CN¥115.8m | CN¥137.0m | CN¥147.0m | CN¥117.6m | CN¥127.2m | CN¥133.7m |
| Diluted earnings per share | 0.22 | 0.24 | 0.29 | 0.31 | 0.27 | 0.36 | 0.40 | 0.33 | 0.35 | 0.37 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥2.05bn | CN¥2.03bn | CN¥1.97bn | CN¥1.84bn | CN¥1.81bn | CN¥2.01bn | CN¥1.60bn | CN¥1.46bn | CN¥1.44bn | CN¥1.35bn |
| Cash and short-term investments | CN¥507.1m | CN¥593.8m | CN¥608.2m | CN¥373.1m | CN¥203.2m | CN¥426.0m | CN¥150.8m | CN¥155.3m | CN¥161.2m | CN¥249.5m |
| Total liabilities | CN¥712.0m | CN¥743.0m | CN¥648.7m | CN¥547.9m | CN¥527.9m | CN¥722.1m | CN¥718.2m | CN¥667.6m | CN¥708.0m | CN¥660.7m |
| Debt | CN¥265.8m | CN¥262.0m | CN¥220.9m | CN¥150.5m | CN¥70.6m | CN¥228.2m | CN¥288.1m | CN¥322.0m | CN¥300.4m | CN¥270.1m |
| Shareholders' equity | CN¥1.27bn | CN¥1.28bn | CN¥1.32bn | CN¥1.29bn | CN¥1.28bn | CN¥1.29bn | CN¥877.1m | CN¥789.7m | CN¥733.5m | CN¥691.6m |
| Shares outstanding | 408m | 372m | 445m | 353m | 423m | 380m | 367m | 362m | 361m | 361m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥115.2m | CN¥109.4m | CN¥236.3m | CN¥213.7m | CN¥108.5m | CN¥148.4m | CN¥182.8m | CN¥132.5m | CN¥74.0m | CN¥133.7m |
| Capital spending | −CN¥92.1m | −CN¥29.9m | −CN¥20.5m | −CN¥23.5m | −CN¥66.2m | −CN¥87.6m | −CN¥77.7m | −CN¥112.6m | −CN¥147.2m | −CN¥173.3m |
| Free cash flow | CN¥23.1m | CN¥79.5m | CN¥215.8m | CN¥190.2m | CN¥42.4m | CN¥60.8m | CN¥105.1m | CN¥19.9m | −CN¥73.2m | −CN¥39.6m |
| Dividends paid | −CN¥81.8m | −CN¥126.1m | −CN¥102.6m | −CN¥94.6m | −CN¥123.4m | −CN¥36.1m | −CN¥61.5m | −CN¥94.4m | −CN¥73.2m | −CN¥58.8m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥439.4m | CN¥349.3m | CN¥558.4m | CN¥393.5m | CN¥343.2m | CN¥271.2m | CN¥513.0m | CN¥332.6m |
| Operating income | CN¥33.3m | CN¥29.6m | CN¥67.2m | CN¥19.6m | CN¥16.2m | CN¥10.8m | CN¥48.3m | CN¥18.1m |
| Net income | CN¥22.1m | CN¥24.3m | CN¥53.7m | CN¥15.4m | CN¥12.4m | CN¥7.8m | CN¥39.5m | CN¥12.4m |
| Diluted earnings per share | 0.05 | 0.06 | 0.13 | 0.04 | 0.03 | 0.02 | 0.11 | 0.03 |
| Cash from operations | — | — | CN¥121.0m | CN¥49.0m | CN¥16.0m | −CN¥71.0m | CN¥120.0m | CN¥26.0m |
| Capital spending | −CN¥15.0m | −CN¥6.0m | −CN¥78.0m | — | −CN¥9.0m | −CN¥3.0m | −CN¥22.0m | −CN¥4.0m |
| Free cash flow | — | — | CN¥43.0m | — | CN¥7.0m | −CN¥74.0m | CN¥98.0m | CN¥22.0m |
| Total assets | CN¥1.97bn | CN¥1.96bn | CN¥2.05bn | CN¥1.98bn | CN¥1.91bn | CN¥1.89bn | CN¥2.03bn | CN¥2.00bn |
| Cash and short-term investments | — | — | CN¥507.1m | CN¥516.0m | CN¥467.5m | CN¥466.0m | CN¥593.8m | CN¥604.4m |
| Debt | — | — | CN¥235.7m | CN¥310.4m | CN¥290.1m | CN¥189.2m | CN¥233.9m | CN¥348.0m |
| Shareholders' equity | CN¥1.22bn | CN¥1.28bn | CN¥1.27bn | CN¥1.23bn | CN¥1.21bn | CN¥1.29bn | CN¥1.28bn | CN¥1.24bn |
Financial ratios
Data as of 16 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 6.7% | 8.3% | 12.0% | 10.5% | 9.8% | 12.8% |
| Net margin | 5.7% | 6.4% | 9.1% | 8.1% | 7.4% | 9.2% |
| Return on equity | 7.0% | 7.0% | 9.8% | 8.5% | 9.0% | 10.6% |
| Return on assets | 4.4% | 4.5% | 6.6% | 6.0% | 6.4% | 6.8% |
| Free cash flow yield | 4.1% | 3.1% | 4.7% | 5.5% | 3.4% | 5.1% |
| Revenue growth | 9.8% | -0.4% | 5.2% | -13.5% | 5.3% | 11.3% |
| Earnings growth | -1.2% | -30.0% | 17.7% | -5.4% | -15.4% | -6.8% |
| Current ratio | 1.82x | 1.90x | 2.04x | 2.10x | 2.04x | 1.73x |
| Debt to equity | 0.18x | 0.18x | 0.16x | 0.11x | 0.05x | 0.18x |
| Equity ratio | 62.3% | 63.3% | 67.0% | 70.2% | 70.9% | 64.2% |
| Interest coverage | 16.91x | 20.33x | 44.22x | 25.23x | 33.06x | 15.02x |
| R&D as a share of sales | 3.3% | 3.1% | 2.0% | 2.3% | 2.2% | 2.2% |
| Buybacks as a share of market value | -9.8% | 16.5% | -26.0% | 16.5% | -11.5% | -3.4% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 4.8% | 1.0% | 3.9% |
| Operating income | -8.5% | -12.6% | -5.1% |
| Net income | -6.6% | -8.2% | -3.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 7.4% | 9.1% | 10.0% | 12.1% |
| Net margin | 6.0% | 7.3% | 7.6% | 9.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 52.6 | 32.5 | 34.2 | 37.4 | 69.9 | 35.1 |
| Price to sales | 3.0 | 2.1 | 3.1 | 3.0 | 5.2 | 3.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 29 Apr 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.20 | 0.20 | 0.30 | 0.25 | 0.23 | 0.30 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.